Report cover image

Tardive Dyskinesia Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine

Publisher Prodture
Published Sep 05, 2024
Length 110 Pages
SKU # PROD19315032

Description

Tardive Dyskinesia Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine


The global tardive dyskinesia market is expected to grow at a CAGR of around 3.1% during 2025-2034. This report on global tardive dyskinesia market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global tardive dyskinesia market by segmenting the market based on type, drug class, end user, and region. Also, detailed profiles of companies operating in the tardive dyskinesia market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increased Neurological Disorders
• Increased Geriatric Population

Market Challenges

• Associated Side Effects

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type

• Bradykinesias
• Hyperkinesias

Market by Drug Class

• Dopamine-Depleting Medications
• VMAT2 Inhibitors
• GABA Receptor Agonist Medications
• Anticholinergic Medications

Market by End User

• Hospitals
• Clinics
• Other End Users

Market by Region

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
• Rest of the World

Table of Contents

110 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Tardive Dyskinesia Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Tardive Dyskinesia Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Tardive Dyskinesia Market by Type
5.1. Introduction
5.2. General tardive dyskinesia
5.3. Hyperlipidemia
5.4. Combined Hyperlipidemia
5.5. Hypoalphalipoproteinemia
6. Global Tardive Dyskinesia Market by Drug Class
6.1. Introduction
6.2. Statin Drugs
6.3. Non-Statin Lipid–Lowering Drugs
7. Global Tardive Dyskinesia Market by End User
7.1. Introduction
7.2. Hospitals
7.3. Homecare
7.4. Specialty Clinics
7.5. Other End Users
8. Global Tardive Dyskinesia Market by Region
8.1. Introduction
8.2. United States
8.3. Germany
8.4. France
8.5. United Kingdom
8.6. Italy
8.7. Spain
8.8. Japan
8.9. Rest of the World
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Abbott Laboratories.
12.2.2. Amgen Inc
12.2.3. Bausch Health
12.2.4. Bionpharma
12.2.5. GlaxoSmithKline Plc.
12.2.6. Johnson & Johnson Services, Inc.
12.2.7. Lannett Co Inc
12.2.8. Lilly
12.2.9. Lupin Pharmaceuticals Inc
12.2.10. Medicure Inc
12.2.11. Mylan N.V
12.2.12. Neurocrine Biosciences, Inc
12.2.13. Novartis AG
12.2.14. Sanofi
12.2.15. Teva Pharmaceutical Industries
List of Figures
Figure 1: Global Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 2: Global Tardive Dyskinesia Market by Type, 2024
Figure 3: Global Tardive Dyskinesia Market by Drug Class, 2024
Figure 4: Global Tardive Dyskinesia Market by End User, 2024
Figure 5: Global Tardive Dyskinesia Market by Region, 2024
Figure 6: Global Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 7: Global Tardive Dyskinesia Market by Type (in %), 2024 & 2034
Figure 8: Global General Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 9: Global General Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 10: Global Bradykinesias Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 11: Global Bradykinesias Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 12: Global Hyperkinesias Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 13: Global Hyperkinesias Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 14: Global Tardive Dyskinesia Market by Drug Class (in %), 2024 & 2034
Figure 15: Global Dopamine-Depleting Medications Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 16: Global Dopamine-Depleting Medications Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 17: Global VMAT2 Inhibitors Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 18: Global VMAT2 Inhibitors Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 19: Global GABA Receptor Agonist Medications Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 20: Global GABA Receptor Agonist Medications Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 21: Global Anticholinergic Medications Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 22: Global Anticholinergic Medications Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 23: Global Tardive Dyskinesia Market by End User (in %), 2024 & 2034
Figure 24: Global Hospitals Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 25: Global Hospitals Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 26: Global Clinics Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 27: Global Clinics Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 28: Global Other End Users Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 29: Global Other End Users Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 30: Global Tardive Dyskinesia Market by Region (in %), 2024 & 2034
Figure 31: United States Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 32: United States Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 33: Germany Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 34: Germany Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 35: France Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 36: France Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 37: United Kingdom Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 38: United Kingdom Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 39: Italy Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 40: Italy Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 41: Spain Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 42: Spain Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 43: Japan Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 44: Japan Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 45: Rest of the World Tardive Dyskinesia Market (in US$ Million), 2020-2024
Figure 46: Rest of the World Tardive Dyskinesia Market (in US$ Million), 2025-2034
Figure 47: Market Value Chain
List of Tables
Table 1: Global Tardive Dyskinesia Market Portraiture
Table 2: Global Tardive Dyskinesia Market by Type (in US$ Million), 2024 & 2034
Table 3: Global Tardive Dyskinesia Market by Drug Class (in US$ Million), 2024 & 2034
Table 4: Global Tardive Dyskinesia Market by Channel (in US$ Million), 2024 & 2034
Table 5: Global Tardive Dyskinesia Market by End User (in US$ Million), 2024 & 2034
Table 6: Global Tardive Dyskinesia Market by Region (in US$ Million), 2024 & 2034
Table 7: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us